gemcitabine has been researched along with bilirubin in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Budman, D; Byrd, J; Egorin, MJ; Hawkins, M; Hohl, R; Hollis, D; Mani, S; Meropol, NJ; Ratain, MJ; Rosner, GL; Venook, AP | 1 |
| Salman, HS; Sparano, JA; Tanaka, K | 1 |
| Miura, T; Nakamura, J; Ozeki, Y; Sato, K; Suzuki, N; Takahashi, T; Yamada, S; Yanagi, M | 1 |
| Hall, PD; Teusink, AC | 1 |
| Benafif, S; Bridgewater, J; Lamarca, A; Ross, P; Valle, JW | 1 |
| Bennouna, J; Caulet, M; Gournay, J; Hautefeuille, V; Lecomte, T; Matysiak-Budnik, T; Prieux-Klotz, C; Salimon, M; Tiako Meyo, M; Touchefeu, Y; Tougeron, D; Zaanan, A | 1 |
| Patel, JA; Piper, JB; Wang, BG | 1 |
| Chae, H; Chang, HM; Cho, H; Hwang, S; Jeong, JH; Kang, J; Kim, KM; Kim, KP; Lee, HC; Lee, JH; Lee, SS; Lee, YJ; Lim, YS; Moon, DB; Park, DH; Ryoo, BY; Shim, JH; Song, GW; Song, TJ; Yoo, C | 1 |
1 review(s) available for gemcitabine and bilirubin
| Article | Year |
|---|---|
[A case of interstitial pneumonia induced by gemcitabine hydrochloride for unresectable bile duct cancer].
Topics: Aged; Anti-Bacterial Agents; Antimetabolites, Antineoplastic; Bile Duct Neoplasms; Bilirubin; Deoxycytidine; Diuretics; Gemcitabine; Humans; Jaundice, Obstructive; Lung Diseases, Interstitial; Male; Pulse Therapy, Drug; Steroids; Tomography, X-Ray Computed | 2009 |
2 trial(s) available for gemcitabine and bilirubin
| Article | Year |
|---|---|
Phase I and pharmacokinetic trial of gemcitabine in patients with hepatic or renal dysfunction: Cancer and Leukemia Group B 9565.
Topics: Aged; Antimetabolites, Antineoplastic; Aspartate Aminotransferases; Bilirubin; Creatinine; Deoxycytidine; Female; Gemcitabine; Humans; Liver Diseases; Liver Function Tests; Male; Middle Aged; Models, Biological; Neoplasms; Renal Insufficiency | 2000 |
Phase I/II trial of gemcitabine plus cyclophosphamide in patients with metastatic breast carcinoma previously treated with taxanes.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Aspartate Aminotransferases; Bilirubin; Bone Neoplasms; Breast Neoplasms; Bridged-Ring Compounds; Cyclophosphamide; Deoxycytidine; Dose-Response Relationship, Drug; Female; Gemcitabine; Humans; Infusions, Intravenous; Liver Neoplasms; Lung Neoplasms; Middle Aged; Survival Analysis; Taxoids; Treatment Outcome | 2002 |
5 other study(ies) available for gemcitabine and bilirubin
| Article | Year |
|---|---|
Toxicities of gemcitabine in patients with severe hepatic dysfunction.
Topics: Alanine Transaminase; Antimetabolites, Antineoplastic; Aspartate Aminotransferases; Bilirubin; Breast Neoplasms; Deoxycytidine; Female; Gemcitabine; Humans; Leukocyte Count; Liver Diseases; Male; Neoplasms; Pancreatic Neoplasms; Platelet Count; Retrospective Studies | 2010 |
Cisplatin and gemcitabine in patients with advanced biliary tract cancer (ABC) and persistent jaundice despite optimal stenting: Effective intervention in patients with luminal disease.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Bilirubin; Biomarkers; Cisplatin; Deoxycytidine; Disease Progression; Disease-Free Survival; Female; Gemcitabine; Humans; Jaundice; Kaplan-Meier Estimate; Male; Middle Aged; Palliative Care; Patient Selection; Proportional Hazards Models; Retrospective Studies; Risk Factors; Stents; Time Factors; Treatment Outcome; United Kingdom; Young Adult | 2015 |
Gemcitabine plus platinum-based chemotherapy for first-line treatment of hepatocholangiocarcinoma: an AGEO French multicentre retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Bilirubin; Carcinoma, Hepatocellular; Cholangiocarcinoma; Cisplatin; Deoxycytidine; Disease Progression; Female; France; Gemcitabine; Hepatitis B Antibodies; Hepatitis C Antibodies; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasms, Complex and Mixed; Oxaliplatin; Progression-Free Survival; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Survival Rate | 2018 |
Follicular dendritic cell sarcoma of the porta hepatis.
Topics: Abdominal Pain; Antineoplastic Combined Chemotherapy Protocols; Bilirubin; Biomarkers, Tumor; Cholangiopancreatography, Endoscopic Retrograde; Dendritic Cell Sarcoma, Follicular; Deoxycytidine; Docetaxel; Gemcitabine; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Taxoids | 2018 |
Prognostic implications of hepatitis B virus infection in intrahepatic cholangiocarcinoma treated with first-line gemcitabine plus cisplatin.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bilirubin; Cholangiocarcinoma; Cisplatin; Deoxycytidine; Female; Gemcitabine; Hepatitis B; Humans; Male; Middle Aged; Prognosis; Retrospective Studies | 2018 |